| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Tumour Tissue Repository and Deeley Research Center, 2 Molecular Oncology and Breast Cancer Program, and 3 Department of Pathology, BC Cancer Agency, Victoria, British Columbia, Canada; 4 Manitoba Breast Tumor Bank and 5 Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada
Requests for reprints: Peter H. Watson, Deeley Research Centre, BC Cancer Agency, Vancouver Island Center, 2410 Lee Avenue, Victoria, BC, Canada V8R 6V5. Phone: 250-519-5700; Fax: 250-519-2009. E-mail: pwatson{at}bccancer.bc.ca
Purpose: Translational cancer research increasingly relies on human tissue biospecimens and this has coincided with a shift in tissue biobanking approach. Newer biobanks (post year 2000) deploy standard operating procedures to reduce variability around biospecimen collection. Because current translational research is based on pre-2000 and post-2000 era biospecimens, we consider whether the collection era may influence gene expression data.
Design: We compared the range of breast tumor collection times from pre-2000 and post-2000 era biobanks and compared estrogen receptor (ER) protein expression with collection time. We then collected 10 breast tumor biospecimens under a standardized protocol and examined whether the expression of c-myc and ER was influenced by storage on ice
24 hours.
Results: The range of collection times achieved at a pre-2000 versus post-2000 era biobank differed. Thirty-two percent of biospecimens were cryopreserved within 30 minutes at the pre-2000 era biobank versus 76% at the post-2000 era biobank. Collection time and ER protein level was inversely correlated (r = –0.19, P = 0.025; n = 137). We observed a wide range in initial c-myc and ER mRNA levels (50- versus 130-fold). Although mRNA levels of both genes declined with increasing collection time, the rate of change differed because c-myc was significantly reduced after 24 hours (mean reduction to 79% of initial) versus ER (94% of initial).
Conclusion: The overall shift in biobanking around the year 2000 is reflected in the ranges of collection times associated with pre-2000 and post-2000 era biobanks. Because collection time can differentially alter gene expression, the biospecimen collection era should be considered in gene expression studies. (Cancer Epidemiol Biomarkers Prev 2008;17(12):3344–50)
This article has been cited by other articles:
![]() |
K. Furuta, K. Yokozawa, T. Takada, and H. Kato Bio-repository of Post-clinical Test Samples at the National Cancer Center Hospital (NCCH) in Tokyo Jpn. J. Clin. Oncol., June 2, 2009; (2009) hyp049v1. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |